News & Updates

Use of linaclotide results in a significant reduction in several abdominal symptoms, such as bloating, discomfort, and pain, among patients with constipation-predominant irritable bowel syndrome (IBS-C) as compared with placebo, according to a study. In addition, reported adverse events (AEs) are in line with the established safety profile.

Neither gastric cancer nor gastric dysplasia is seen in patients with corpus atrophic gastritis (CAG) characterized at baseline with corpus pseudopyloric metaplasia (PPM) without corpus intestinal metaplasia (IM) because such lesions are consistently associated with corpus IM, reports a study.

Acute pancreatitis has seen a steady increase in worldwide incidence over the last five decades, particularly in Western countries, a recent study has found.

Functional abdominal pain among inflammatory bowel disease children in remission (IBP-FAPD) is common and leads to worse fatigue and lower health-related quality of life (HR-QoL), a recent study has found. Past disease severity does not significantly predict IBP-FAPD.

Intravenous dosing regimens of vedolizumab appear to favourably alter outcomes in patients with fistulizing Crohn’s disease, according to data from the phase IV ENTERPRISE trial.

Treatment with azathioprine helps prevent relapse of autoimmune pancreatitis, according to the results of a systematic review and meta-analysis.

Majority of patients with chronic pancreatitis also have osteoporosis or osteopenia, with risk factors including older age and lower body mass index, among others, according to a study.